USPTO serial 98933777
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: August 12th, 2026
Encore M&A, Inc.
Denver, CO, US
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical device for treating cancer | ACTIVE | — |
| Date | Code | Event |
|---|---|---|
| May 12, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| May 12, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| May 12, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Aug 28, 2025 | DOCK | ASSIGNED TO EXAMINER |
| Aug 27, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Aug 27, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 2, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Jan 2, 2025 | NWAP | NEW APPLICATION ENTERED |